18272031Bradley DA, Dunn R, Nanus D, Stadler W, Dreicer R, Rosenberg J, Smith DC, Hussain MClinical genitourinary cancerAntineoplastic Agents; Indoles; Pyrroles; Urinary Bladder NeoplasmsDisease Progression; Double-Blind Method; Endpoint Determination; Humans; Receptors, Vascular Endothelial Growth Factor; Research Design; Sunitinib; Vascular Endothelial Growth Factor ARandomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study design. Clin Genitourin Cancer. 2007 Dec; 5(7):460-3.Clin Genitourin Cancer2007-12-01T00:00:002007Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study design.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000970Chemicals & Drugs40723500.435194Antineoplastic AgentsD001749Disorders1093660.741843Urinary Bladder NeoplasmsD004311Procedures33818160.710891Double-Blind MethodD007211Chemicals & Drugs1333170.850447IndolesAuthorship 342624D006801Living Beings2259861020.130171Humans0.08081150.08081151authors10.2511has subject areaD018450Physiology49515260.701966Disease ProgressionD023381Procedures37600.972258Endpoint DeterminationD011758Chemicals & Drugs621840.890595PyrrolesD012107Concepts & IdeasLiving BeingsProcedures2505930.749027Research DesignD040262Chemicals & Drugs36680.966746Receptors, Vascular Endothelial Growth FactorD042461Chemicals & Drugs1564070.84404Vascular Endothelial Growth Factor AMedicineUniversity of ChicagoWalter M.StadlerWalter M. Stadler41.78927490000000-87.601250000000001904Stadler, Walter M.Professortrue1ProfessorProfessor